Papers in Visualized Cancer Medicine
Page 1 · newest first
- Multifunctional nanoparticles in colorectal cancer therapy: Advances in targeted drug delivery systemsVisualized Cancer Medicine · 2026
- Diagnostic experiences of patients with cervical cancer: A qualitative study in Accra Metropolis, GhanaVisualized Cancer Medicine · 2026
- Transanal total mesorectal excision: Current status, clinical outcomes and future perspectivesVisualized Cancer Medicine · 2026
- Hepatic parenchymal resection with waterjet in the malignant setting – Results of an Initial ForayVisualized Cancer Medicine · 2025
- Advances in basic and translational research on the heterogeneity and metastatic mechanisms of primary liver cancerVisualized Cancer Medicine · 2025
- Tumor-infiltrating lymphocyte therapy: therapeutic advances and prospectsVisualized Cancer Medicine · 2025
- Recent progress in the treatment of locally advanced head and neck squamous cell carcinomasVisualized Cancer Medicine · 2025
- Cancer therapeutics hope: microRNA clinical practice and perspectivesVisualized Cancer Medicine · 2025
- Enabling clinical use of linear energy transfer in proton therapy for head and neck cancer – A review of implications for treatment planning and adverse events studyVisualized Cancer Medicine · 2025
- Review of radiotherapy combined with systemic therapy for advanced esophageal cancer: from chemotherapy to immunotherapy eraVisualized Cancer Medicine · 2025
- Targeting myofibroblastic cancer-associated fibroblasts (myCAFs): a promising strategy for overcoming tumor progression and immunotherapy resistanceVisualized Cancer Medicine · 2025
- Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatableVisualized Cancer Medicine · 2025
- From single-cell snapshots to spatial panoramas – a holistic multiomics map of glioblastomaVisualized Cancer Medicine · 2025
- The next steps for chemo-optimization in lung cancer treatmentVisualized Cancer Medicine · 2025
- Revisiting the role of cell death in cancer – promotion rather than inhibitionVisualized Cancer Medicine · 2025
- Inspiring art pieces and legendary stories for cancer patients and medical staff: experience from a single institutionVisualized Cancer Medicine · 2024
- Beam range uncertainty and its clinical management in particle therapyVisualized Cancer Medicine · 2024
- Updates on altered signaling pathways in tumor drug resistanceVisualized Cancer Medicine · 2024
- Roles of heat shock proteins in tumor immune microenvironmentVisualized Cancer Medicine · 2024
- Promoting music intervention training in oncology in China: Challenges, opportunities, and pathways forwardVisualized Cancer Medicine · 2024
- Tumor mineralization-based cancer diagnosis and therapyVisualized Cancer Medicine · 2024
- Enhancing real-world studies with artificial intelligence: addressing ethical and quality challengesVisualized Cancer Medicine · 2024
- Artificial intelligence plus molecular profiling for personalized radiotherapy: Questions 105–107 in the 150 most important questions in cancer research and clinical oncology seriesVisualized Cancer Medicine · 2024
- Revisiting and proposing the most important questions in cancer research and clinical oncologyVisualized Cancer Medicine · 2024
- The 150 most important questions in cancer research and clinical oncology series: questions 102–104Visualized Cancer Medicine · 2024
- Integrin α6 targeted cancer imaging and therapyVisualized Cancer Medicine · 2023
- Functions of glutaminyl cyclase and its isoform in diseasesVisualized Cancer Medicine · 2023
- Challenges and benefits of implementing DIBH for breast cancer radiotherapy: Experiences from Guangzhou Concord Cancer CenterVisualized Cancer Medicine · 2023
- The first reported case of a patient with small cell lung cancer treated with fan beam computed tomography-guided online adaptive radiotherapyVisualized Cancer Medicine · 2023
- Semaphorin 4C accelerates disease progression and enables disease detection in breast cancerVisualized Cancer Medicine · 2023
- Friend or Foe? The fascinating Tudor-SN proteinVisualized Cancer Medicine · 2023
- Loss of monoacylglycerol O-acyltransferase 2 can be compensated for by diacylglycerol O-acyltransferases 1 and 2 resulting in a negligible influence on mammary cancer development found in a mouse model and verified in human tissuesVisualized Cancer Medicine · 2023
- Benefits of precision medicine in lung cancer: experience from a single institutionVisualized Cancer Medicine · 2022
- CBP/p300 bromodomain: new promising epigenetic targetVisualized Cancer Medicine · 2022
- An increase in early cancer detection rates at a single cancer center: Experiences from Sun Yat-sen University Cancer CenterVisualized Cancer Medicine · 2022
- MxA: a broadly acting effector of interferon-induced human innate immunityVisualized Cancer Medicine · 2022
- Metastasis of nasopharyngeal carcinoma: What we know and do not knowVisualized Cancer Medicine · 2021
- The innovation and clinical application of ischemia-free organ transplantationVisualized Cancer Medicine · 2021
- Clinical advances in nasopharyngeal carcinoma surgery and a video demonstrationVisualized Cancer Medicine · 2021
- Dosimetric comparison of intensity-modulated proton radiotherapy versus intensity-modulated photon-based radiotherapy for breast cancerVisualized Cancer Medicine · 2021